201 related articles for article (PubMed ID: 12911418)
1. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites.
Potter PC;
Allergy; 2003 Sep; 58(9):893-9. PubMed ID: 12911418
[TBL] [Abstract][Full Text] [Related]
2. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.
de Blic J; Wahn U; Billard E; Alt R; Pujazon MC
Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959
[TBL] [Abstract][Full Text] [Related]
3. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
4. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
5. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
[TBL] [Abstract][Full Text] [Related]
6. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
[TBL] [Abstract][Full Text] [Related]
7. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
[TBL] [Abstract][Full Text] [Related]
8. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Stübner P; Zieglmayer R; Horak F
Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
Potter PC;
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):175-80. PubMed ID: 16136768
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study.
Segall N; Gawchik S; Georges G; Haeusler JM
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116
[TBL] [Abstract][Full Text] [Related]
11. Potential of levocetirizine in the relief of nasal congestion.
Klimek L
Int J Clin Pract; 2005 Jun; 59(6):721-9. PubMed ID: 15924602
[TBL] [Abstract][Full Text] [Related]
12. Levocetirizine as treatment for symptoms of seasonal allergic rhinitis.
Jorissen M; Bertrand B; Stiels B; Vandenbulcke K
B-ENT; 2006; 2(2):55-62. PubMed ID: 16910288
[TBL] [Abstract][Full Text] [Related]
13. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
[TBL] [Abstract][Full Text] [Related]
14. Levocetirizine: a new selective H1 receptor antagonist for use in allergic disorders.
Day JH; Ellis AK; Rafeiro E
Drugs Today (Barc); 2004 May; 40(5):415-21. PubMed ID: 15319796
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of levocetirizine in seasonal allergic rhinitis.
Leynadier F; Mees K; Arendt C; Pinelli ME
Acta Otorhinolaryngol Belg; 2001; 55(4):305-12. PubMed ID: 11859651
[TBL] [Abstract][Full Text] [Related]
16. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
[TBL] [Abstract][Full Text] [Related]
17. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
18. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
[TBL] [Abstract][Full Text] [Related]
20. The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study).
Guilemany JM; García-Piñero A; Alobid I; Centellas S; Mariño FS; Valero A; Bernal-Sprekelsen M; Picado C; Mullol J
Int Arch Allergy Immunol; 2012; 158(2):184-90. PubMed ID: 22286639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]